RESUMO
Gypenosides (GP), the main medicinal ingredient of Gynostemma Pentaphyllum Makino, exhibits excellent protective effect on various neural diseases through several mechanisms, including anti-inflammation, anti-oxidative stress and pro-neural regeneration. In the current review, we have made a summary on the research progress of GP on neural disorders, like Alzheimer' s disease, Parkinson' s disease, depression, hypoxic brain injury and so on, aiming to provide an experimental basis for the further research and drug development of GP.
RESUMO
<p><b>OBJECTIVE</b>To study the distribution of polymorphism of c.212-37insC (rs3832879) in intron 1 of fibroblast growth factor 23 (FGF23) gene and its association with Kawasaki disease (KD) and coronary artery lesions (CAL).</p><p><b>METHODS</b>Forty children with KD were enrolled in this study, among whom 16 children had concurrent CAL. Twenty-six age-matched healthy children were enrolled as controls. PCR and gene sequencing were applied to explore the distribution of polymorphism of c.212-37insC (rs3832879) in FGF23 gene in KD patients and controls.</p><p><b>RESULTS</b>Among 40 children with KD, 14 (35%) carried the polymorphism of c.212-37insC (rs3832879) in FGF23 gene; among 26 controls, 6 (23%) carried such polymorphism. There was no significant difference in genotype distribution at this locus between the two groups (P=0.30). Among 16 children with CAL, 9 (56%) carried the polymorphism at this locus; among 24 children without CAL, 5 (21%) carried such polymorphism. As for the comparison of two subgroups with and without CAL, the difference in genotype distribution at this locus had statistical significance (P=0.02, OR=4.89, 95% CI: 1.21-19.71).</p><p><b>CONCLUSIONS</b>The polymorphism of c.212-37insC (rs3832879) in FGF23 gene may not be associated with the pathogenesis of childhood KD, but it may be associated with the development of CAL in children with KD.</p>